top of page
Picture 2.png

Contact Us

About Us

The Medical Supply Company of Switzerland 

The Medical Supply Company of Switzerland (MSCS) is a wholesale supplier of healthcare products and medical equipment that provides organizations, governments and hospital association with a one stop solution for the procurement, supply and delivery of equipment and consumables.

Founded by Marco Illy, former member of the Executive Board at Credit Suisse, MSCS has served organizations worldwide in procuring reliable quality medical supplies at efficient prices.
 

  • Procurement, supply & delivery of medical equipment and consumables. 
     

  • Hospital & Healthcare facility Development incl. planning and project management.
     

  • COVID-19 supply of personal protective equipment and tests.
     

As a Swiss majority-owned institution MSCS continues to pave the way into becoming a truly global network enabling the unique demands of our clients – be they Governmental or Institutional. Through our internal capabilities and global partnerships, we can supply quality medical equipment and consumables at efficient prices, as well as superior services in the healthcare industry including Hospital and Healthcare facility development. 

"Swiss Efficiency
Global Presence" 

Artboard 41000 ppi.png
Business%20picture_edited.jpg

Marco Illy

President

Marco Illy is President and the controlling shareholder of MSCS. His profile is well known in Switzerland having been one of its pre-eminent bankers for many years, acting as Head of Investment Banking in German Speaking Europe and Member of the Executive Board of Credit Suisse (Switzerland) Ltd. During this period Mr. Illy gained his healthcare sector experience having advised on the sale of Synthes to J&J, Actelion to J&J, the demergers of Ciba and Syngenta from Novartis, and Givaudan from Roche, Zimmer's acquisition of Centrepulse, the divestiture of Alcon from Nestle, as well as on the IPOs of Idorsia and DKSH. He is also Member of the Board of Directors of Innosuisse – Switzerland’s government owned innovation agency, Compagnie Financiere Tradition – a financial conglomerate listed on the Swiss stock exchange, and RocketVax – a biotech startup developing next-generation vaccines.

bottom of page